Diabetes

28 June 2011

New hurdle for diabetes vaccine

An experimental vaccine to prevent progression of type 1 diabetes failed at the second step of the three-phase trial process, doctors said in a study.

0

An experimental vaccine to prevent progression of type 1 diabetes failed at the second step of the three-phase trial process, doctors said in a study reported online by The Lancet.

The vaccine sought to protect insulin-producing beta cells in the pancreas from the body's immune system.

Its formula is based on an enzyme called glutamic acid decarboxylase (GAD), which the over-sensitised immune system targets –and in doing so destroys the precious beta cells.

The idea was that by vaccinating patients with GAD, this would teach the immune system's T cells to tolerate the enzyme.

The trial was carried out on 145 patients aged three to 45 years living in the United States and Canada who had been diagnosed with Type 1 diabetes within the previous three months.

The volunteers were given either the vaccine; the vaccine plus a standard immune-system booster; or just the booster alone.

Patients in all three groups experienced similar progression in the disease, with no difference among them in side effects.

The paper, led by Jay Skyler of the University of Miami Miller School of Medicine, was presented at a conference of the American Diabetes Association in San Diego, California.

Refusing to give up

Despite the setback, the investigators called for more research to see if the formula might work when administered sooner or as part of a combination therapy.

The number of adults with diabetes worldwide has more than doubled since 1980, with almost 350 million now affected, according to data reported earlier at the conference.

Diabetes is caused by poor blood sugar control and can lead to heart disease and stroke and damage the kidneys, nerves and eyes.

High blood sugar levels and diabetes kill three million people across the world each year. The surge is attributed to longer lifespan and excess weight, especially among women.

Type 1, a condition that affects about five to 10% of people with diabetes, was previously known as juvenile diabetes because it typically shows up in children or young adults. Patients have to take daily insulin shots for the rest of their lives and follow dietary guidelines and exercise.

In type 2 diabetes, previously known as adult-onset diabetes, either the body does not produce enough insulin or cells are resistant to the hormone. The condition is managed by diet, exercise as well as insulin shots if need be.

(Sapa, June 2011)

Read more:

Diabetes condition centre

Diabetes doubled since 1980

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.

Ask the Expert

Diabetes expert

Dr. May currently works as a fulltime endocrinologist and has been in private practice since 2004. He has a variety of interests, predominantly obesity and diabetes, but also sees patients with osteoporosis, thyroid disorders, men's health disorders, pituitary and adrenal disorders, polycystic ovaries, and disorders of growth. He is a leading member of several obesity and diabetes societies and runs a trial centre for new drugs.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules